Category: CovidienSyndicate content

Covidien wins FDA nod for Fortrex PTA balloon catheter

November 24, 2014 by Brad Perriello

Covidien says it won 510(k) clearance from the FDA for its Fortrex PTA balloon catheter, designed both for maintaining blood vessel access for hemodialysis and for treating peripheral artery disease.

Covidien wins FDA nod for Fortrex PTA balloon catheter

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.

Will Stryker bid on Smith & Nephew this week?

UPDATED Nov. 24 with analysis from Morgan Stanley.

Covidien wins home-use CE Mark for Nellcor oxygen monitor

November 21, 2014 by Val Kennedy

Covidien says it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

Covidien wins CE Mark for Nellcor oxygen monitor

Covidien (NYSE:COV) said it won CE Mark approval in the European Union for home use of its Nellcor bedside SpO2 patient monitoring system.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MDT prepares $10B worth of bonds to help fund its $43B acquisition of COV | The week in medtech M&A

November 19, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Report: Medtronic readies $10B bond flotation for Covidien deal; Medtech mergers stayed strong in Q3; Sources: Philips attracts private equity bids for lighting unit; Medtronic, Covidien set timetable for shareholders meetings; Report: Actavis may buy Allergan for at least $60 billion

Report: Medtronic readies $10B bond flotation for Covidien deal

November 17, 2014 by Brad Perriello

Medtronic, Covidien set timetable for shareholders meetings

November 17, 2014 by Brad Perriello

Medtronic and Covidien set the timetable for shareholder meetings to vote on their pending, $43 billion merger.

Medtronic, Covidien set timetable for shareholders meetings

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

DeviceTalks closes 2014 season in Orange County this week

November 17, 2014 by Brian Johnson

Pioneering live interview series from MassDevice.com will close its 2014 season this week in Irvine, Calif. with Masimo CEO Joe Kiani and Caroll Neubauer, CEO, B. Braun Medical.

MassDevice.com On Call

DeviceTalks, the live interview series featuring thought leaders from the $126B medical technology industry, closes out its 2014 season on November 19, 2014 in Irvine, Calif. with a conversation focused on whether the medical device industry is doing enough to protect patients.

Covidien study: VenaSeal effective in treating leg veins

November 17, 2014 by Val Kennedy

A Covidien study has shown that its new VenaSeal system is just as effective in treating chronic leg vein disorders as its ClosureFast ablation catheter.

Covidien study: VenaSeal effective in treating leg veins

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp